Les médicaments génériques sont aussi de qualité, sûrs et efficaces.

L’agence fédérale des médicaments et des produits de santé (afmps)
lance une campagne visant à souligner la qualité, la sécurité et l’efficacité des médicaments génériques.

Clicquez iciExternal link pour plus d’information. 


Spot 1 (MP3, 1.15 MB)

Spot 2 (MP3, 1.15 MB)

Human use

Veterinary use

A clear vision of the future - Annual report 2013

image RA 2013 cover

 The annual report “A clear vision of the future – Annual report 2013” is available :

♦ in English (PDF, 8.4 MB) - Flipbook
External link
♦ in French (PDF, 12.73 MB) - FlipbookExternal link
♦ in Dutch (PDF, 14.38 MB) - FlipbookExternal link

 You can also ask for a paper copy of this annual report (as long as available) by mail to: comm@fagg-afmps.be



  • To the attention of holders of MA’s: new definition for the approval date mentioned in SmPC and PIL.


    When the administratively closing of a variation or renewal leads to an update of the marketing authorization (MA), a new methodology to determine the approval date mentioned in the summary of product characteristics (SmPC) and patient leaflet (PIL) will be used from 15/6/15.

    read more
  • VIG-NEWS: January 2015 Edition


    The new edition of the electronic newsletter "VIG-NEWS" of the federal agency for medicines and health products (famhp) is now available. The VIG-NEWS is a selection of recent news concerning pharmacovigilance from different sources.

    read more
  • Call Center “registration”: Expansion team in 2015


    Due to an underemployment within the Call Center Registration in 2014, this resulted in a delay in the processing of the daily requests send to registration@fagg.be. In the meantime the team has been expanded and a procedure has been worked out in order to absorb the delayed requests. As for the new requests, a workflow has been worked out in order to increase the efficiency.

    read more


Last updated on 04 May 2015

of a medicine

(PIL: patient information leaflet SPC: summary of product characteristics)


Subscribe to our newsletter

Your e-mail